The authors observed 1693 newborn infants during the first ten days of life. Vitamin K was administered to 711 of these infants, and the plasma prothrombin was investigated in 606. As might be expected, the prothrombin of the plasma from the cord was the same as that of the mother. After birth the plasma prothrombin diminished in quantity for three days, but thereafter increased until the seventh day, when it had usually returned to the original value. Administration of Vitamin K to the infant raised the prothrombin value substantially, as also did administration to the mother before the birth.
In this investigation it was found that the giving of Vitamin K did not affect the frequency of haemorrhagic manifestations. Conjunctival, petechial, vaginal, cerebral and umbilical haemorrhages were just as frequent, and there were just as many cases of melaena and cephalematomas in the treated infants as in the controls.
The authors did not consider that any of the infants really suffered from haemorrhagic disease of the newborn. Though they found no difference between the number of cerebral haemorrhages in the infants treated with Vitamin K and in the untreated cases, they are not prepared to dismiss his form of therapy since there is no other specific remedy. The Vitamin K will raise the blood prothrombin value within a few hours and its administration will certainly do no harm.
During the last five years the authors have found that Vitamin C is consistently low in infants who develop cerebral haemorrhage, and they recommend that where this condition is suspected Vitamin C should be administered.
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